The FDA is currently weighing the drug flibanserin, developed by pharmaceutical company Boehringer Ingelheim to boost female sexual drive, for possible sale in the US. Aside from the questions of whether it’s safe or whether low sex drive is really a medical condition, the FDA released an initial report questioning whether flibanserin even works.
A Food and Drug Administration review of data on the effectiveness of flibanserin — a pill anticipated to become the first “female Viagra” — resulted in questions about how well the drug will actually work in treating premenopausal women suffering from low sex drive.
According to a report posted on the FDA website Wednesday, when compared with a placebo, the response rate of Flibanserin was “not compelling,” and the drug yielded only slight improvements for treating hypoactive sexual desire disorder or HSDD.
I hope flibanserin or some other female viagra gets approved, if only for the inevitable onslaught of TV ads.
